Endocannabinoids--at the crossroads between the gut microbiota and host metabolism. (Q35871872)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26678807%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

title

Endocannabinoids--at the crossroads between the gut microbiota and host metabolism (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26678807%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26678807%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Hubert Plovier

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26678807%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Matthias Van Hul

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26678807%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Nathalie M. Delzenne

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26678807%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

4

Lucie Geurts

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26678807%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

6

Céline Druart

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26678807%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

7

Amandine Everard

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26678807%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

publication date

18 December 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26678807%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Endocrinology

2 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26678807%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26678807%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26678807%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

133-143

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26678807%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrendo.2015.211

2 March 2020

exact match

0 references

cites work

Monitoring host responses to the gut microbiota

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

The role of the gut microbiota in energy metabolism and metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Host-gut microbiota metabolic interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Animals in a bacterial world, a new imperative for the life sciences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Structure, function and diversity of the healthy human microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

A human gut microbial gene catalogue established by metagenomic sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Microbial ecology of the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

The gut microbiome as therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

An integrated catalog of reference genes in the human gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Host-bacterial mutualism in the human intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Worlds within worlds: evolution of the vertebrate gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

A core gut microbiome in obese and lean twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Human genetics shape the gut microbiome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16S rRNA abundance, and community cellular fatty acid profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

High throughput sequencing reveals distinct microbial populations within the mucosal and luminal niches in healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

A crypt-specific core microbiota resides in the mouse colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

The gut microbiota of rural papua new guineans: composition, diversity patterns, and ecological processes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Linking long-term dietary patterns with gut microbial enterotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Diet rapidly and reproducibly alters the human gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Towards a more comprehensive concept for prebiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Prebiotic effects: metabolic and health benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Keeping gut lining at bay: impact of emulsifiers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Richness of human gut microbiome correlates with metabolic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Gut metagenome in European women with normal, impaired and diabetic glucose control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Alterations of the human gut microbiome in liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

The religious and medicinal uses of Cannabis in China, India and Tibet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Molecular characterization of a peripheral receptor for cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Endocannabinoid signaling at the periphery: 50 years after THC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Omega-3 N-acylethanolamines are endogenously synthesised from omega-3 fatty acids in different human prostate and breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Endocannabinoids, related compounds and their metabolic routes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

The orphan receptor GPR55 is a novel cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Anandamide and vanilloid TRPV1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Endocannabinoids as regulators of transient receptor potential (TRP) channels: A further opportunity to develop new endocannabinoid-based therapeutic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Regulation of GPR119 receptor activity with endocannabinoid-like lipids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Endocannabinoid biosynthesis and inactivation, from simple to complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Endocannabinoids and their oxygenation by cyclo-oxygenases, lipoxygenases and other oxygenases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Metabolism of endocannabinoids and related N-acylethanolamines: canonical and alternative pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Endocannabinoid signalling and the deteriorating brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anandamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon N-palmitoylethanolamine levels and counteracts murine colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Advances in the discovery of N-acylethanolamine acid amidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Brain monoglyceride lipase participating in endocannabinoid inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Glucose metabolism: focus on gut microbiota, the endocannabinoid system and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Endocannabinoids and energy homeostasis: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Obesity-driven synaptic remodeling affects endocannabinoid control of orexinergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

The role of endocannabinoids in the regulation of gastric emptying: alterations in mice fed a high-fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re-feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Palmitoylethanolamide normalizes intestinal motility in a model of post-inflammatory accelerated transit: involvement of CB₁ receptors and TRPV1 channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Intestinal lipid-derived signals that sense dietary fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Acute activation of cannabinoid receptors by anandamide reduces gastrointestinal motility and improves postprandial glycemia in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Anti-inflammatory effect of palmitoylethanolamide on human adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

The endocannabinoid system links gut microbiota to adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

The gut microbiota as an environmental factor that regulates fat storage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Metabolic endotoxemia initiates obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Lipopolysaccharide induces anandamide synthesis in macrophages via CD14/MAPK/phosphoinositide 3-kinase/NF-kappaB independently of platelet-activating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Lipopolysaccharide downregulates fatty acid amide hydrolase expression and increases anandamide levels in human peripheral lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Proinflammatory stimuli control N-acylphosphatidylethanolamine-specific phospholipase D expression in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Chronic endocannabinoid system stimulation induces muscle macrophage and lipid accumulation in type 2 diabetic mice independently of metabolic endotoxaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Pharmacological effects of cannabinoids on the Caco-2 cell culture model of intestinal permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

21 January 2018

Glucagon-like peptides

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Modulation of Glucagon-like Peptide-1 (GLP-1) Potency by Endocannabinoid-like Lipids Represents a Novel Mode of Regulating GLP-1 Receptor Signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Gut microbiota and GLP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Intestinal epithelial MyD88 is a sensor switching host metabolism towards obesity according to nutritional status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Adipose tissue NAPE-PLD controls fat mass development by altering the browning process and gut microbiota.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Altered gut microbiota and endocannabinoid system tone in obese and diabetic leptin-resistant mice: impact on apelin regulation in adipose tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Silencing of mitochondrial Lon protease deeply impairs mitochondrial proteome and function in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

CB(1) signaling in forebrain and sympathetic neurons is a key determinant of endocannabinoid actions on energy balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Cannabinoids and the gut: new developments and emerging concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Feeding-induced oleoylethanolamide mobilization is disrupted in the gut of diet-induced obese rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Oleoylethanolamide enhances β-adrenergic-mediated thermogenesis and white-to-brown adipocyte phenotype in epididymal white adipose tissue in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Harnessing the anti-inflammatory potential of palmitoylethanolamide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-α activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Palmitoylethanolamide prevents metabolic alterations and restores leptin sensitivity in ovariectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Obesity alters gut microbial ecology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Possible endocannabinoid control of colorectal cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Neural contractions in colonic strips from patients with diverticular disease: role of endocannabinoids and substance P

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Endocannabinoid overactivity and intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Gastrointestinal endocannabinoid system: multifaceted roles in the healthy and inflamed intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Altered endocannabinoid signalling after a high-fat diet in Apoe(-/-) mice: relevance to adipose tissue inflammation, hepatic steatosis and insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Endocannabinoids in liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

A peripheral endocannabinoid mechanism contributes to glucocorticoid-mediated metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Peripheral cannabinoid-1 receptor inverse agonism reduces obesity by reversing leptin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Peripherally restricted CB1 receptor blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Prospective therapeutic agents for obesity: molecular modification approaches of centrally and peripherally acting selective cannabinoid 1 receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

A comprehensive patents review on cannabinoid 1 receptor antagonists as antiobesity agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Peripheral selectivity of the novel cannabinoid receptor antagonist TM38837 in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Synthesis and characterization of a peripherally restricted CB1 cannabinoid antagonist, URB447, that reduces feeding and body-weight gain in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

The endocannabinoid system, eating behavior and energy homeostasis: the end or a new beginning?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

The therapeutic potential of GPR119 agonists for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Development of the first potent and specific inhibitors of endocannabinoid biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

A novel fluorophosphonate inhibitor of the biosynthesis of the endocannabinoid 2-arachidonoylglycerol with potential anti-obesity effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Implication of the anti-inflammatory bioactive lipid prostaglandin D2-glycerol ester in the control of macrophage activation and inflammation by ABHD6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

The serine hydrolase ABHD6 Is a critical regulator of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Optimization of 1,2,5-thiadiazole carbamates as potent and selective ABHD6 inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Discovery of glycine sulfonamides as dual inhibitors of sn-1-diacylglycerol lipase α and α/β-hydrolase domain 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Proteome-wide reactivity profiling identifies diverse carbamate chemotypes tuned for serine hydrolase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

A common haplotype in NAPEPLD is associated with severe obesity in a Norwegian population-based cohort (the HUNT study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Inhibition of fatty acid amide hydrolase (FAAH) as a novel therapeutic strategy in the treatment of pain and inflammatory diseases in the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

FAAH deficiency promotes energy storage and enhances the motivation for food

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

N-acylphosphatidylethanolamine, a gut- derived circulating factor induced by fat ingestion, inhibits food intake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Potential modulation of plasma ghrelin and glucagon-like peptide-1 by anorexigenic cannabinoid compounds, SR141716A (rimonabant) and oleoylethanolamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

An anorexic lipid mediator regulated by feeding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Fat to treat fat: emerging relationship between dietary PUFA, endocannabinoids, and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Krill oil significantly decreases 2-arachidonoylglycerol plasma levels in obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Synthesis and pharmacological activity of a potent inhibitor of the biosynthesis of the endocannabinoid 2-arachidonoylglycerol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Artificial sweeteners induce glucose intolerance by altering the gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Hashish. IV. The isolation and structure of cannabinolic cannabidiolic and cannabigerolic acids

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Analysis of the “endocannabinoidome” in peripheral tissues of obese Zucker rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

The fatty acid amide hydrolase (FAAH)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

The endogenous cannabinoid system stimulates glucose uptake in human fat cells via phosphatidylinositol 3-kinase and calcium-dependent mechanisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Cannabinoid receptor 1 (CB1) antagonism enhances glucose utilisation and activates brown adipose tissue in diet-induced obese mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Overactivity of the intestinal endocannabinoid system in celiac disease and in methotrexate-treated rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Diacylglycerol Lipase α Knockout Mice Demonstrate Metabolic and Behavioral Phenotypes Similar to Those of Cannabinoid Receptor 1 Knockout Mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

α/β-Hydrolase domain-6-accessible monoacylglycerol controls glucose-stimulated insulin secretion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Stearoylethanolamide exerts anorexic effects in mice via down-regulation of liver stearoyl-coenzyme A desaturase-1 mRNA expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Dietary DHA reduces downstream endocannabinoid and inflammatory gene expression and epididymal fat mass while improving aspects of glucose use in muscle in C57BL/6J mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2015.211

Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

31 March 2020

1 reference

12 December 2020

Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing

1 reference

12 December 2020

Determination and characterization of a cannabinoid receptor in rat brain

1 reference

12 December 2020

The palmitoylethanolamide and oleamide enigmas : are these two fatty acid amides cannabimimetic?

1 reference

12 December 2020

The composition of the gut microbiota throughout life, with an emphasis on early life.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRENDO.2015.211

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26678807%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference